メモリー機能を有するT細胞又はB細胞の増強剤、悪性腫瘍再発抑制剤、及びT細胞又はB細胞にメモリー機能を誘導する誘導剤
An object of the present invention is to provide an enhancer for endogenous T-cells or B-cells having a memory function and a malignant tumor recurrence inhibitor in order to continue to reject malignant tumor over a long period of time. An enhancer for T-cells or B-cells having a memory function in...
Saved in:
Format | Patent |
---|---|
Language | Japanese |
Published |
03.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | An object of the present invention is to provide an enhancer for endogenous T-cells or B-cells having a memory function and a malignant tumor recurrence inhibitor in order to continue to reject malignant tumor over a long period of time. An enhancer for T-cells or B-cells having a memory function in an administration subject, comprising a nucleic acid delivery vehicle, a nucleic acid encoding interleukin-7 (IL-7), and a nucleic acid encoding chemokine (C-C motif) ligand 19 (CCL19), and an inducer for inducing a memory function in T-cells or B-cells in an administration subject, are prepared. Also, a malignant tumor recurrence inhibitor comprising a nucleic acid delivery vehicle, a nucleic acid encoding interleukin-7 (IL-7), and a nucleic acid encoding CCL19, is prepared. |
---|---|
Bibliography: | Application Number: JP20190548200 |